SUBJECT INDEX 



971 



excretion pattern, 782 



lethal dose, 719-720 



paramecia, 751 



resistance factor in E. coli, 759 



resistance factor in trypanosomes, 758 



structure of, 601 

 3,4-DichIorotoluene, fungal growth, 573 

 1,2-Dienolglucose, antagonism of alloxan, 



388-389 

 Diethoxy-coenzyme Q,q, succinate oxi- 

 dase, 475 

 Diethylarsenoxide, fibroblast growth, 770 

 Diethylstilbestrol. mitosis, 522-523 

 2,5-Difluoro-p-benzoquinone, fungal 



growth, 565 

 Digitalis glycosides, see Ouabain 

 Dihydrofolate reductase, arsenite, 656 

 Dihydrolipoate dehydrogenase, arsenite, 



618, 621, 628, 646, 649 

 Dihydroorotase, iV-ethylmaleimide, 348 

 Dihydroorotate dehydrogenase, arsenite, 



656 

 Dihydroxy acid dehydratase, 



iV-ethylmaleimide, 348 



o-iodosobenzoate, 803 



SH reagent comparison, 803 



silver, 803 

 2,5 - Dihydroxy - p - benzoquinone, oxida- 

 tion-reduction potential, 430 

 5,8-Dihydroxymenadione, enzyme inhi- 

 bitions, 446 

 1 ,2-Dihydroxy-5,8-naphthoquinone, car- 



cinostasis, 540 

 2,3-Dihydroxy- 1 ,4-naphthoquinone, 



autoxidation, 433 



fibroblast mitosis, 531 



inflammatory activity, 505 



oxidation-reduction potential, 430 



succinate dehydrogenase, 459 

 5,8-Dihydroxy- 1 ,4-naphthoquinone, 



enzyme inhibitions, 452 



FADHa oxidation, 477 

 Dihydroxyphenylalanine, see Dopa 

 Dihydroxyphenylalanine decarboxylase, 



see Dopa decarboxylase 

 Dimercaprol (BAL), 



antagonism of alloxan, 388 



fatty acid biosynthesis, 660 



oxidative phosphorylation, potentia- 

 tion of arsenite, 659-662 

 reactions with arsenicals, 610-611 



2,3 - Dimercaptoaceto - 1,4 - naphthoqui- 

 none, fibroblast mitosis, 528, 534 



2,3-Dimercaptopropiono-l,4-naphthoqui- 

 none, fibroblast mitosis, 534 



2,5-Dimethoxy-23-benzoquinone, 

 enzyme inhibitions, 449, 455 

 fungal growth, 563, 566 

 methemoglobin formation, 516 



2,6-Dimethoxy-7J-benzoquinone, 

 bacterial growth, 544-549 

 enzyme inhibitions, 447, 449, 455 

 fungal growth, 563, 566, 568-569 

 methemoglobin formation, 516 

 muscle contracture, 499 

 planaria, 576 



Diniethoxy-p-benzoquinones, oxidation- 

 reduction potentials, 430 



2,3-Dimethoxy-l,4-naphthoquinone, 

 fungal growth, 566 

 pyruvate decarboxylase, 457, 573 

 spore germination, 573 



3,5-Dimethoxytoluquinone, 



bacterial growth, 544-547, 549-551, 



554-555 



bacterial infections, 559 



corneal irritation, 504 



lethal dose, 509 



metabolism of, 583 



A^iV-Dimethylalloxan, diabetogenic ac- 

 tion, 385-386 



p-Dimethylaminoazobenzene (butter yel- 

 low), 



carcinogenicity, 539 

 conversion to dimethylphenylenedia- 

 mine, 586 



oxidation products of, enzyme inhibi- 

 tions, 539 



A-(4-Dimethylamino-3,5-dinitrophenyl) 

 maleimide, determination of SH groups, 

 340 



p - Dimethylaminophenylarsenoxide, tis- 

 sue binding in vivo, 724 



Dimethylarsenoxide, fibroblast growth, 

 770 



Dimethylarsinite, see Cacodylate 



